Style de citation APA (7e éd.)

MM, O., A, T., H, K., R, M., BI, A., MB, R., . . . NR, P. (2019). TKI-resistant ALK-rearranged lung adenocarcinoma with secondary CTNNB1 p.S45V and tertiary ALK p.I1171N mutations. Dove Medical Press.

Style de citation Chicago (17e éd.)

MM, Ouseph, Taber A, Khurshid H, Madison R, Aswad BI, Resnick MB, Yakirevich E, Ali SM, et Patel NR. TKI-resistant ALK-rearranged Lung Adenocarcinoma with Secondary CTNNB1 P.S45V and Tertiary ALK P.I1171N Mutations. Dove Medical Press, 2019.

Style de citation MLA (8e éd.)

MM, Ouseph, et al. TKI-resistant ALK-rearranged Lung Adenocarcinoma with Secondary CTNNB1 P.S45V and Tertiary ALK P.I1171N Mutations. Dove Medical Press, 2019.